This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Rite Aid Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 0/6

Rite Aid şirketinin toplam hissedar öz sermayesi $-2.0B ve toplam borcu $3.8B olup, bu da borç-öz sermaye oranını -191.6% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $7.1B ve $9.1B dir.

Anahtar bilgiler

-191.6%

Borç/özkaynak oranı

US$3.77b

Borç

Faiz karşılama oranı	n/a
Nakit	US$97.12m
Eşitlik	-US$1.97b
Toplam yükümlülükler	US$9.09b
Toplam varlıklar	US$7.13b

Son finansal sağlık güncellemeleri

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: RADC.Q negatif hissedar özkaynağı var; bu, kısa vadeli varlıkların kısa vadeli yükümlülükleri karşılamamasından daha ciddi bir durumdur.

Uzun Vadeli Yükümlülükler: RADC.Q şirketinin negatif özkaynağı bulunmaktadır; bu, kısa vadeli varlıkların uzun vadeli yükümlülükleri karşılamamasından daha ciddi bir durumdur.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: RADC.Q negatif hissedar özkaynağı var ki bu yüksek borç seviyesinden daha ciddi bir durumdur.

Borcun Azaltılması: RADC.Q 'in negatif özkaynağı var, dolayısıyla borcunun zaman içinde azalıp azalmadığını kontrol etmemize gerek yok.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: RADC.Q şirketinin mevcut serbest nakit akışına dayanarak yeterli nakit pistine sahip olup olmadığını belirlemek için yeterli veri yok.

Tahmini Nakit Akışı: RADC.Q tarihsel oranlara göre serbest nakit akışı büyümeye veya küçülmeye devam ederse yeterli nakit pistine sahip olup olmadığını belirlemek için yeterli veri yok.

This company listing is no longer active

Rite Aid Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 0/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Motion for Asset Sale Approved for Rite Aid Corporation

Second Amended Reorganization Plan & Dsiclosure Statement Filed by Rite Aid Corporation

Rite Aid Corporation announced delayed 10-Q filing

NYSE Suspends Trading in Rite Aid

Rite Aid Corporation Filed for Bankruptcy

Rite Aid Corporation Filed for Bankruptcy

Recent updates

Rite Aid Corporation Announces Resignation of Jeffrey S. Stein, as Chief Restructuring Officer

Rite Aid Announces Availability of Opill At All Locations

Motion for Asset Sale Approved for Rite Aid Corporation

Second Amended Reorganization Plan & Dsiclosure Statement Filed by Rite Aid Corporation

Rite Aid Corporation (OTCPK:RADC.Q) acquired Tuttles Pharmacy Inc from Pellegrini family.

Rite Aid Corporation announced delayed 10-Q filing

Robbins Geller Rudman & Dowd LLP Announces Proposed Settlement in the Rite Aid Corporation Securities Litigation

Rite Aid Corporation Announces Board Appointments

Rite Aid Corporation(OTCPK:RADC.Q) dropped from S&P TMI Index

Rite Aid Corporation(OTCPK:RADC.Q) dropped from S&P Global BMI Index

NYSE Suspends Trading in Rite Aid

Rite Aid Corporation Filed for Bankruptcy

Rite Aid Shareholders Are Wiped Out Under A Chapter 11 Bankruptcy Plan

Rite Aid Corporation Filed for Bankruptcy

Rite Aid Corporation announced delayed 10-Q filing

Rite Aid Corporation Receives Written Notice from the New York Stock Exchange

Rite Aid Corporation is Heading Towards Bankruptcy

Rite Aid and Bartell Drugs Announce Availability of Appointments for Updated COVID-19 Vaccine

Rite Aid Announces Availability of OTC NARCAN Nasal Spray At All Locations

Rite Aid Corporation Announces Availability of Flu and RSV Vaccine Appointments at All Locations

New minor risk - Share price stability

Rite Aid Corporation Announces Executive Changes

Rite Aid Corporation, Annual General Meeting, Jul 26, 2023

Rite Aid May Be Forced Into Ch.11 Bankruptcy To Resolve Opioid Liabilities

Consensus EPS estimates fall by 52%, revenue upgraded

New minor risk - Shareholder dilution

Rite Aid Corporation, Annual General Meeting, Aug 18, 2023

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Rite Aid Q1 Earnings Preview: Bears Remain In Control

Rite Aid Corporation(NYSE:RAD) dropped from Russell Small Cap Comp Growth Index

Rite Aid Corporation to Report Q1, 2024 Results on Jun 29, 2023

Rite Aid Corporation Names Thomas Sabatino Chief Legal Officer

Rite Aid Announces Launch of RYSHI Beauty and Personal Care Essentials

Elixir Announces the Next Wave of Innovation for Pharmacy Benefits Technology Platform

Consensus EPS estimates fall by 67%, revenue upgraded

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Price target decreased by 22% to US$3.00

Department of Justice Intervenes in Baron & Budd Whistleblower Lawsuit Against Rite Aid

Rite Aid Corporation Announces Departure of Heyward Donigan as President and as A Member of the Board

Rite Aid names interim CEO as Heyward Donigan departs

Price target decreased to US$3.67

Price target decreased to US$3.83

Rite Aid Corporation Provides Earnings Guidance for the Fiscal Year 2023

Rite Aid Q3 2023 Earnings Preview

Rite Aid Corporation to Report Q3, 2023 Results on Dec 21, 2022

Bronstein, Gewirtz & Grossman, LLC Notifies Rite Aid Corporation (RAD) Investors of Class Action and Encourages Investors to Actively Participate

Insufficient new directors

Rite Aid spikes 20% on above average volume

Bronstein, Gewirtz & Grossman, LLC Files Lawsuit Against Rite Aid Corporation and Certain of Its Officers

Rite Aid Corporation Investors with Substantial Losses Have Opportunity to Lead the Rite Aid Class Action Lawsuit

Rite Aid partners with Google Cloud on pharmacy insights, customer engagement

Second quarter 2023 earnings: EPS misses analyst expectations

Rite Aid Corporation Announces Impairment Charges for the Second Quarter Ended August 27, 2022

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin